The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II study of nivolumab (anti-PD1), tadalafil, and oral vancomycin in patients with refractory primary hepatocellular carcinoma or liver dominant metastatic cancer from colorectal or pancreatic cancers.
 
M. Cecilia Monge B.
No Relationships to Disclose
 
Changqing Xie
No Relationships to Disclose
 
Donna Mabry-Hrones
No Relationships to Disclose
 
Bradford J. Wood
No Relationships to Disclose
 
Seth M. Steinberg
No Relationships to Disclose
 
David E Kleiner
No Relationships to Disclose
 
Tim F. Greten
No Relationships to Disclose